RPG Life Sciences Ltd Stock Price Today (NSE: RPGLIFE)
Fundamental Score
RPG Life Sciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
RPG Life Sciences Ltd share price today is ₹2302.00, up +0.58% on NSE/BSE as of 17 June 2026. RPG Life Sciences Ltd (RPGLIFE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹3.68K (Cr). The 52-week high for RPGLIFE share price is ₹2725.00 and the 52-week low is ₹1733.00. At a P/E ratio of 33.04x, RPGLIFE is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 25.53% and a debt-to-equity ratio of 0.00.
RPG Life Sciences Ltd Share Price Chart — NSE/BSE Historical Performance
RPG Life Sciences Ltd share price chart: 10.98% return over the past month. 52-week high ₹2725.00, 52-week low ₹1733.00.
RPG Life Sciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹2183.50 | ₹2232.00 | ₹2170.00 | ₹2192.70 | 4.85K (Cr) | |
| ₹2224.00 | ₹2224.00 | ₹2163.30 | ₹2172.40 | 3.36K (Cr) | |
| ₹2235.10 | ₹2258.80 | ₹2187.20 | ₹2224.70 | 12.04K (Cr) | |
| ₹2221.00 | ₹2246.00 | ₹2200.00 | ₹2232.60 | 10.59K (Cr) | |
| ₹2253.70 | ₹2300.70 | ₹2205.00 | ₹2213.70 | 5.79K (Cr) | |
| ₹2308.00 | ₹2327.90 | ₹2243.00 | ₹2253.70 | 10.26K (Cr) | |
| ₹2274.20 | ₹2329.00 | ₹2253.60 | ₹2293.90 | 5.92K (Cr) | |
| ₹2300.00 | ₹2330.90 | ₹2269.90 | ₹2274.20 | 3.76K (Cr) | |
| ₹2285.80 | ₹2355.00 | ₹2285.00 | ₹2300.00 | 10.01K (Cr) | |
| ₹2273.00 | ₹2332.00 | ₹2273.00 | ₹2282.60 | 4.49K (Cr) |
RPG Life Sciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹2224.00 | ₹2232.00 | ₹2163.30 | ₹2192.70 | -1.41% | |
| ₹2314.00 | ₹2524.90 | ₹2187.20 | ₹2224.70 | -3.86% | |
| ₹1941.10 | ₹2336.60 | ₹1840.40 | ₹2295.00 | +18.23% | |
| ₹1764.70 | ₹1985.00 | ₹1733.00 | ₹1857.70 | +5.27% | |
| ₹1981.00 | ₹2093.80 | ₹1864.00 | ₹1874.40 | -5.38% | |
| ₹2322.30 | ₹2357.90 | ₹1880.00 | ₹2007.90 | -13.54% | |
| ₹2297.40 | ₹2392.20 | ₹2175.00 | ₹2322.30 | +1.08% | |
| ₹2413.50 | ₹2480.00 | ₹2196.00 | ₹2278.10 | -5.61% | |
| ₹2234.20 | ₹2483.80 | ₹2210.80 | ₹2403.90 | +7.60% | |
| ₹2302.10 | ₹2463.20 | ₹2225.00 | ₹2234.20 | -2.95% | |
| ₹2385.10 | ₹2401.40 | ₹2247.50 | ₹2320.50 | -2.71% | |
| ₹2530.00 | ₹2725.00 | ₹2197.50 | ₹2401.00 | -5.10% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
RPG Life Sciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
RPG Life Sciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of RPGLIFE across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (25.53%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (32.80%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.43%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (38.23%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (28.54% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (28.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (265.64x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹325.36 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (72.95%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 7.81%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
RPG Life Sciences Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare RPG Life Sciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
RPG Life Sciences LtdRPG Life Scienc...Selected✓ RPGLIFE • 532983 | 62/100 | ₹2302.00₹2302 | ₹3682.76₹3682.76 | 33.04Average 33.0 Average | 25.53%Excellent 25.53% Excellent | 32.80%Excellent 32.80% Excellent | 0.00Excellent 0.0 Excellent | 28.54%Excellent 28.54% Excellent | 11.71%Good 11.71% Good | 0.90% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
RPG Life Sciences Ltd PE Ratio History
Historical price-to-earnings ratio for RPGLIFE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹110.80 | ₹2322.30 | 21x |
| FY 2024 | ₹53.01 | ₹2184.45 | 41.2x |
| FY 2023 | ₹40.90 | ₹1335.85 | 32.7x |
| FY 2022 | ₹31.13 | ₹847.05 | 27.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
RPG Life Sciences Ltd Dividend History
Annual cash dividends paid by RPGLIFE — dividend yield 0.90%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹26.46 Cr |
| FY 2024 | ₹19.85 Cr |
| FY 2023 | ₹15.88 Cr |
| FY 2022 | ₹11.91 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
RPG Life Sciences Ltd Quarterly Performance
Latest quarterly metrics for RPGLIFE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.50%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
38.23%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
11.71%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
28.54%
Compounded annual net profit growth over 5 years
RPG Life Sciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for RPGLIFE — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
RPG Life Sciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for RPG Life Sciences Ltd (RPGLIFE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for RPG Life Sciences Ltd
About RPGLIFE (RPG Life Sciences Ltd)
RPG Life Sciences Ltd is a dynamic pharmaceutical entity operating on both Indian and global stages. The company's core business revolves around the creation, production, and distr...ibution of a wide array of pharmaceutical products. These include branded formulations targeting specific therapeutic needs, cost-effective generic medications ensuring wider accessibility, and the fundamental building blocks of many drugs – synthetic Active Pharmaceutical Ingredients (APIs). With a robust infrastructure and a focus on scientific advancement, RPG Life Sciences is committed to delivering high-quality healthcare solutions. Their efforts are geared towards addressing various medical needs through innovation and the efficient production of reliable pharmaceutical products. The company's API portfolio is particularly noteworthy, encompassing a range of therapeutic categories that address critical health concerns. These APIs are designed to treat a spectrum of conditions, including autoimmune disorders requiring immunosuppression, mental health challenges addressed by anti-psychotics, and cardiovascular ailments alleviated by anti-anginals. Furthermore, they produce APIs for combating parasitic infections with anthelmintics, managing neurological conditions with anti-convulsants, and easing muscular discomfort with anti-spasmodics. This broad spectrum of API production reflects RPG Life Sciences' dedication to supplying the pharmaceutical industry with the essential components needed to manufacture a diverse range of medications. Beyond APIs, RPG Life Sciences is also a significant player in the generics market, particularly in the realm of immunosuppressant therapy. These generic alternatives provide cost-effective treatment options for patients requiring long-term immunosuppression, often critical after organ transplantation or for managing autoimmune diseases. In addition, the company develops and distributes finished dosage formulations designed for direct patient use. These formulations cover a range of therapeutic areas, underscoring the company's commitment to providing comprehensive pharmaceutical solutions. RPG Life Sciences aims to enhance the quality of life for patients worldwide through its dedication to pharmaceutical innovation and accessibility.
Company Details
Key Leadership
Corporate Events
RPGLIFE Share Price: Frequently Asked Questions
What is the current share price of RPG Life Sciences Ltd?
RPG Life Sciences Ltd (RPGLIFE) trades at ₹2302.00 on NSE and BSE. Market cap ₹3.68K (Cr). Educational data only.
What is the P/E ratio of RPG Life Sciences Ltd?
RPG Life Sciences Ltd has a P/E of 33.04x vs industry average 31.77x.
What is the Bull Run score for RPG Life Sciences Ltd?
RPG Life Sciences Ltd has a Bull Run score of 62/100 based on 25+ financial parameters.
Does RPG Life Sciences Ltd pay dividends?
RPG Life Sciences Ltd has a dividend yield of 0.90%. Past dividends don't guarantee future payments.
What is the ROE of RPG Life Sciences Ltd?
RPG Life Sciences Ltd has ROE of 25.53%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of RPG Life Sciences Ltd?
RPG Life Sciences Ltd has debt-to-equity of 0.00.
Is RPG Life Sciences Ltd a good investment?
Bull Run gives RPG Life Sciences Ltd a score of 62/100. This is not investment advice — consult a SEBI-registered advisor.